Showing results (11-20 of 293) with videos related to
Sort By:
Pageof 30
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 9, 2023
Radioimmunoscintigraphy and Pretreatment Dosimetry of <sup>131</sup>I-Omburtamab for Planning Treatment of Leptomeningeal DiseaseNeeta Pandit-Taskar, Milan Grkovski, Pat B Zanzonico, et al.Pediatric Blood & Cancer|January 17, 2016
Feasibility of Administering High-Dose (131) I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined RoomsBae P Chu, Christopher Horan, Ellen Basu, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2021
Biodistribution and Radiation Dosimetry of Intraperitoneally Administered <sup>124</sup>I-Omburtamab in Patients with Desmoplastic Small Round Cell TumorsMilan Grkovski, Shakeel Modak, Pat B Zanzonico, et al.Pediatric Blood & Cancer|November 2, 2007
Transient sialoadenitis: a complication of 131I-metaiodobenzylguanidine therapyShakeel Modak, Neeta Pandit-Taskar, Brian H Kushner, et al.Clinical Nuclear Medicine|June 27, 2008
F-18 FDG uptake in cutaneous metastases from breast cancerSunita Borkar, Neeta Pandit-TaskarClinical Nuclear Medicine|October 9, 2015
Foot and Ankle Hepatocellular Carcinoma MetastasisKalind Parashar, Neeta Pandit-TaskarClinical Nuclear Medicine|October 17, 2017
Uncommon Metastasis to the Pancreas From Adenocarcinoma of the Cervix Detected on Surveillance 18F-FDG PET/CT ImagingSonia Mahajan, Neeta Pandit-TaskarSeminars in Nuclear Medicine|October 16, 2020
Immune-Directed Molecular Imaging BiomarkersNeeta Pandit-Taskar, Michael A PostowMolecular Imaging and Biology|September 22, 2021
ImmunoPET: harnessing antibodies for imaging immune cellsAnna M Wu, Neeta Pandit-TaskarJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 9, 2016
Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II StudyShakeel Modak, Pat Zanzonico, Jorge A Carrasquillo, et al.Pageof 30